Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation

31 Oct 2023

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Lymphoblastic Leukemia research
Share to Acute Myeloid Leukemia Research
Share to Hematopoietic Stem Cell Transplantation

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 37913908
DOI: 10.1016/j.jtct.2023.10.018

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell TransplantationPMID 37913908Read ↗

Allogeneic hematopoietic stem cell transplantation and the risk for transmission of heritable malignancy.Semantic proximity Read ↗

Allogeneic transplantation and the risk for transmission of genetic disease: the heritable cancer disorders.Semantic proximity Read ↗

Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disordersSemantic proximity Read ↗

Genetic variation and hematopoietic stem cell transplantation: expansion of the paradigm.Semantic proximity Read ↗

Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMTSemantic proximity Read ↗

Defining genetic risk for graft-versus-host disease and mortality following allogeneic hematopoietic stem cell transplantation.Semantic proximity Read ↗

[Hematopoietic cell transplantation in the era of genome analysis].Semantic proximity Read ↗

Risk assessment in haematopoietic stem cell transplantation: pre-transplant patient and donor factors: non-HLA genetics.Semantic proximity Read ↗

Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipientsSemantic proximity Read ↗

Transplant genetics and genomics.Semantic proximity Read ↗

MHC-resident variation affects risks after unrelated donor hematopoietic cell transplantation.Semantic proximity Read ↗

Haematopoietic stem cell transplantation: can our genes predict clinical outcome?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.